All News
Telehealth hangs in balance as spending bill in question
In this edition STAT's Health Tech: Uncertainty over if expiring pandemic-era telehealth provisions would be extended, and more.
Read MoreA deep dive on Makary, Vertex’s pain data, & 2025 predictions
STAT's Readout LOUD podcast discusses Trump's pick for FDA chief and offers a year-end round of questions and predictions about biopharma in 2025.
Read MoreWhat Are ‘Healthy’ Foods? New Rules for Labeling Are Issued.
The Food and Drug Administration released final rules on labeling foods as “healthy,” tightening limits for sugar, sodium and saturated fat.
Read MoreFDA updates rules for which foods are “healthy,” adding salmon and nuts and cutting sugary cereals
The updated definition allows more food to qualify as healthy, including higher fat fish, nuts, seeds, and certain oils.
Read MoreTirzepatide Officially Off FDA's Shortage List
(MedPage Today) -- The shortage of the diabetes and obesity injectable tirzepatide (Mounjaro, Zepbound) has been resolved, the FDA announced Thursday.
Read MoreMosunetuzumab in Follicular Lymphoma: Durable Responses and Manageable Safety
(MedPage Today) -- At the recent American Society of Hematology (ASH) annual meeting, updated data on mosunetuzumab (Lunsumio) in relapsed/refractory follicular lymphoma revealed durable responses, p
Read MoreFDA Approves Mesenchymal Stromal Cell Therapy for Refractory Acute GVHD in Kids
(MedPage Today) -- Reaching the end of a long road to approval, the first mesenchymal stromal cell (MSC) therapy for steroid-refractory acute graft-versus-host disease (GVHD) finally reached the FDA
Read MoreThere’s little evidence of a ‘brain microbiome’ | Letter
Prof Mark Pallen, Dr Aimee Parker, Prof Nick Loman and Prof Alan Walker take issue with an article that discussed the existence of a brain microbiome and its impact on diseasesContrary to what is impl
Read MoreTrump’s Return May Worsen Financial Woes for Global Health Institutions
The U.S. provides nearly half of the aid for global health, including childhood vaccination, H.I.V. treatment and disease surveillance.
Read MoreEvolving Testing and Diagnostic Paradigms in Alzheimer's Disease
(MedPage Today) -- The author of this article is an employee of Eli Lilly and Company. Every 65 seconds, someone in the U.S. develops Alzheimer's disease.
Read More